tffpharma.com - Volume dana dhuwit perusahaan TFFP

Simbol resmi perusahaan TFF Pharmaceuticals, Inc. (TFFP)

TFF Pharmaceuticals is winding down its operations, transparently selling off patents due to a capital shortage. Free cash flow levels confirm this decline, where 0.00 records a new baseline. Asset value now relies on the success of partners rather than economic phases. Meanwhile, legal protections in the US completely eliminate the risks of external trade sanctions.

TFFP - Volume dana dhuwit perusahaan TFF Pharma ing rentang 04.07.2022 - 21.12.2024

Rincian metrik lan analitis perusahaan TFF Pharmaceuticals, Inc. (TFFP)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:tffpharma.com
Produk mawa merek tffpharma.com

The development of freeze-drying technologies by TFF Pharmaceuticals (TFFP) correlates directly with the dynamics of cash on the balance sheet. This indicator captures actual cash balances, determining the business's real margin of safety against market shocks. The metric measures liquidity through the difference between licensing inflows and operating expenses. While excess capital guarantees survival, it may reduce the overall return on assets, rendering the asset a defensive tool.

Pesaing TFF Pharmaceuticals

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dhuwit awis perusahaan LQDA|Galapagos Genomics (GLPG) - Aset likuid perusahaan|Volume dana dhuwit perusahaan ANIP|Dhuwit awis perusahaan Afrezza MNKD|Dana dhuwit perusahaan Amphastar AMPH|Aset likuid perusahaan Pacira BioSciences (PCRX)|ARS Corp - Volume dana dhuwit perusahaan|TBPH: Dana dhuwit perusahaan|AQST: Volume dana dhuwit perusahaan|SCPH - Aset likuid perusahaan|TECX (Tectonic) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tonix Pharmaceuticals Holding Corp. TNXP|Dana dhuwit perusahaan SXT Pharmaceuticals (SXTC)|Volume dana dhuwit perusahaan Eupraxia Pharmaceuticals Inc. (EPRX)|Dana dhuwit perusahaan BioHarvest Sciences BHST|EXOZ (Invizyne) - Total volume dana dhuwit perusahaan|ORMP: Dhuwit awis perusahaan|ENTX (Entera Bio Ltd) - Dhuwit awis lan setara dhuwit awis perusahaan|HYFT: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan QNTM|Volume dana dhuwit perusahaan FGEN|Dhuwit awis perusahaan Telomir Pharmaceuticals TELO|Volume dana dhuwit perusahaan RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Total volume dana dhuwit perusahaan|RLYB - Dana dhuwit perusahaan|LEXX (Lexaria Bioscience Corp.) - Dhuwit awis lan setara dhuwit awis perusahaan|pulmatrix.com (PULM) - Dana dhuwit perusahaan|PTHL (Pheton) - Dana dhuwit perusahaan|Dana dhuwit perusahaan Aptorum|Cadangan dhuwit perusahaan Lyra Therapeutics Inc. LYRA|Volume dana dhuwit perusahaan IBO|TNFA (TNF Pharmaceuticals, Inc.) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan cbdMD, Inc. YCBD|Sisa dhuwit perusahaan PRFX|Altamira Therapeutics Ltd. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Lipella Pharmaceuticals Inc|OPTN: Volume dana dhuwit perusahaan|Pieris - Sisa dhuwit perusahaan|Dhuwit awis perusahaan PROC|Volume dana dhuwit perusahaan petrospharma.com|Dana dhuwit perusahaan Qilian International Corp (QLI)|Volume dana dhuwit perusahaan ACELYRIN (SLRN)